Microsoft word - lachmancol-6-3.doc

September, 2006
Volume 6, No. 3

Larry Lachman, PsyD

Blood pressure and insulin improved with transcendental meditation
Maura Paul-Labrador, MPH and her colleagues at Cedars-Sinai Medical Center in Los Angeles report
that in a study of 103 subjects with stable coronary heart disease who were randomized to undergo 16
weeks of either Transcendental Meditation or health education, those who practiced TM showed
greater improvement in blood pressure, insulin resistance and cardiac nervous system tone than the
control group that underwent general health education. Paul-Labrador and her colleagues partially
conclude by writing, “These results suggest that TM may modulate the physiological response to stress
and improve CHD risk factors, which may be a novel therapeutic target for the treatment of
CHD…demonstrating beneficial physiological effects of transcendental meditation in the absence of
effects on psychosocial variables, suggest that transcendental meditation may modulate response to
stress rather than alter the stress itself, similar to the physiological impact of exercise conditioning.”
Archives of Internal Medicine (2006;166:1218-1224)
After two failures, a third antidepressant showed to be mainly ineffective
Dr. Maurizio Fava and colleagues from the Massachusetts General Hospital report that in a study of
235 adults who initially did not derive benefit from the antidepressant Celexa (citalopram) or other
subsequent antidepressants, were then randomized and given either Remeron (mirtazapine) or Aventyl
(nortriptyline). The results showed that the remission rates from either one of these third-prescribed
anti-depressants were about the same—at approximately 20% (Nortriptyline- 19.8%; mirtazapine-
12.3%), leading to the conclusion that two prior unsuccessful antidepressant trials usually spell
treatment failure or low remission rates for a third. The report quotes American Journal of Psychiatry
Editor-In-Chief Dr. Robert Freedman as saying, “By the third wave of the study, the rate of remission
continues to be quite low, which underscores the persistence of depression and its resistance to current

American Journal of Psychiatry (2006; 163:1123-1125, 1161-1172) Chronic insomnia better helped by cbt than imovane
Psychologist Borge Siversten, Psy.D. and colleagues from the University of Bergen in Norway report
that in a study of 46 adults with chronic primary insomnia treated at an out-patient clinic, those who
were randomized to receive cognitive behavioral therapy as opposed to either receiving the medication,
Imovane (zopiclone) or placebo, showed greater improvement in total wake time, total sleep time, sleep
efficiency and slow-wave sleep than either the medication or placebo groups. For most measures,
medication effects were no greater than placebo and at the 6-month follow-up, the CBT group still
showed greater sustained improvement in sleep efficiency than the medication or placebo groups. The
authors partly conclude by writing, “These results suggest that interventions based on CBT are superior
to zopiclone treatment both in short- and long-term management of insomnia in older adults.”
Journal of the American Medical Association (2006: 295; 2851-2858),

Suicide risk and elevated omega-6/omega-3 ratios
Dr. J. John Mann and colleagues at Columbia University report that in a two-year prospective study of
33 subjects with major depressive disorder who were given the Hamilton Depression Rating Scale and
the Beck Scale for Suicidal Ideation, those who later attempted suicide showed a lower
docosahexaenoic acid (omega-3) percentage of total phospholipid fatty acids and a higher omega-
6/omega-3 ratios. Dr. Mann states that depressive disorders have been connected with low levels of
omega-3 plasma polyunsaturated fatty acids and elevated omega-6/omega-3 ratios. He writes,
“…augmentation with omega-3 plasma polyunsaturated fatty acids is reportedly therapeutic…If
confirmed, this finding would have implications for the neurobiology of suicide and reduction of suicide
American Journal of Psychiatry (2006; 163: 1100-1102)
Prostate cancer progression slowed by pomegranate juice
The peer-reviewed journal of the American Association of Cancer Research, Dr. Allan Pantuck and
colleagues at UCLA report that in a study of 50 men who had undergone either surgery or radiation
treatment for prostate cancer and then showed signs of the cancer rapidly returning—measured by how
long it took for the prostate-specific antigen levels to double—those who drank pomegranate juice
showed a significant slowing of the doubling PSA rate and returning disease (24 months to double vs.
15 months for the men not drinking pomegranate juice) apart from any other treatment intervention. It
is theorized that besides the known anti-inflammatory and anti-oxidant effects of pomegranate juice, the
isoflavones also contained in the juice are thought to have a role in cancer cell death. Dr. Pantuck partly
concludes by writing, “In older men 65 to 70 who have been treated for prostate cancer, we can give
them pomegranate juice and it may be possible for them to outlive their risk of dying from their cancer.
"We are hoping we may be able to prevent or delay the need for other therapies usually used in this
population such as hormone treatment or chemotherapy, both of which bring with them harmful side
Clinical Cancer Research, (12, 4018-4026)
Larry Lachman, PsyD, is a Licensed Clinical Psychologist based in Monterey, California, who
specializes in Psycho-Oncology, Cardiac Psychology, Pain Management and Grief and Loss. Dr.
Lachman is the co-author with Carmel Poet/Philosopher Ric Masten of a book on coping with cancer
entitled, “Parallel Journeys.” Dr. Lachman is an adjunct instructor at the California School of
Professional Psychology-At Alliant International University in San Francisco and can be reached
through his web site at:

The International Journal of Healing and Caring On Line is distributed electronically. You may choose to print your downloaded copy for relaxed reading. Feel free to forward this to The International Journal of Healing and Caring
P.O. Box 76, Bellmawr, NJ 08099
Phone (609) 714-1885 - Fax (609) 714-3553
Email: Web Site:
Copyright 2001 IJHC. All rights reserved.


Microsoft word - 037-07.doc

AHF Arbeitsgemeinschaft historischer Forschungseinrichtungen AHF-Information Nr. 037 vom 26.03.2007 Medizintechnik – mehr als Apparatemedizin Technikgeschichtliche Tagung 2007 des Vereins Deutscher Ingenieure e.V. Am 22. und 23. Februar 2007 führte der Bereich Technikgeschichte des Vereins Deutscher Ingenieure in Düsseldorf die Technikgeschichtliche Jahrestagung 2007 durch. Unter


STORA RIDHUSET Domare: Ann-Sophie Annerstedt DRESSYR kort bana Sponsras av Susanne Widners H&R 30 Näsuddens Jolly Heart DRESSYR lång bana Sponsras av EquusIT AB ca 11:30-11:45 Prisutdelning Dressyrklasser PLATS: STORA RIDHUSET Domare: Ann-Sophie Annerstedt TÖMKÖRNING DRESSYR VUXNA HÄSTAR Sponsras av EquusIT AB UNGHÄSTAR Sponsras av Susann

Copyright © 2010-2019 Pdf Physician Treatment